Olga Salamero

10PUBLICATIONS
74CO-AUTHORS
NanomedicineOtorhinolaryngologyCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 06, 2026
Venetoclax-based therapy versus hypomethylating agents alone in unfit patients with newly diagnosed acute myeloid leukemia: a real-world study from the PETHEMA registry.

|Apr 22, 2026
Real-World Outcomes of FLAG-Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA Study.

|Jan 11, 2025
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.

Guadalupe Oñate, Ana Garrido, Montserrat Arnan

|May 05, 2023
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.

Guadalupe Oñate, Marta Pratcorona, Ana Garrido

|Jun 01, 2022
Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan.

Francesca Guijarro, Alex Bataller, Marina Diaz-Beyá

|Dec 31, 2021
Prognostic impact of micromegakaryocytes in primary myelodysplastic syndromes.

Sílvia Saumell, Miranda Fernández-Serrano, Alba Mesa

Pageof 2

Frequent Collaborators

4 joint publications

Mar Tormo

4 joint publications

Pau Montesinos

3 joint publications

Jorge Sierra

3 joint publications

Antònia Sampol